Innoviva (INVA) Misses Q4 EPS by 6c

Innoviva (NASDAQ: INVA) reported Q4 EPS of $0.26, $0.06 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $91.81 million versus the consensus estimate of $84.3 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.

You May Also Be Interested In

• JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
• Investec Double Upgrades Alkem Laboratories Ltd (ALKEM:IN) to Buy
• ICICI Securities Downgrades Manappuram Finance Ltd (MGFL:IN) to Hold (3)